Karmanos Recognitions

Michigan Cancer Consortium

Michigan Cancer ConsortiumThe Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website

Goals of Consortium and its members include:

  • Prevent cancer from occurring
  • Promote early detection of cancer using tests that have been shown to reduce mortality
  • Diagnose and treat all patients using the most effective and appropriate methods
  • Optimize quality of life for every person affected by cancer

The Latest From Karmanos Cancer Institute

News

Medical Student Research Symposium Winners Announced, 3 Students Mentored by Karmanos Faculty

The winners of the 2024 Wayne State University (WSU) School of Medicine’s Medical Student Research Symposium have been announced. Three of the med...

Read More

Researchers Evaluate Uptake of Screening, Risk-Reducing Recommendations Among BRCA1 and BRCA2 Carriers at Karmanos Cancer Center

Researchers at the Barbara Ann Karmanos Cancer Institute took a deep dive into the significance of breast cancer screening and the recommendations...

Read More

IN THE NEWS: Women Now Advised to Get Mammogram Every Other Year Starting at 40

WJR The new U.S. Preventative Services Task Force recommendations state that women should receive mammograms every other year starting at 40. Howe...

Read More
News

WJR | Women Now Advised to Get Mammogram Every Other Year Starting at 40

Listen Now

Cancer History Project | Surviving Lung Cancer Focused Morhaf Al Achkar’s Career on Addressing Health Disparities

Listen Now

WOLB | Prostate Cancer Among African American Men

Listen Now